Evidence map›Paper›PMID 37012543›Full record

ArticleNature immunology2023

Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control.

Rosemary V Swanson, Ananya Gupta, Taylor W Foreman, Lan Lu, Jose Alberto Choreno-Parra, Stanley Kimbung Mbandi, Bruce A Rosa, Sadia Akter, Shibali Das, Mushtaq Ahmed and 12 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Therapeutic remodeling of the tuberculosis granuloma with 1-methyl-D-tryptophan enhances CD8Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. CD8Nature communications · 2026
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 5 countries.

Rosemary V Swanson *Department of Molecular Microbiology, Washington University in St. Louis, St. Louis, MO, USA.
Ananya Gupta *Department of Molecular Microbiology, Washington University in St. Louis, St. Louis, MO, USA.
Taylor W ForemanDivisions of Bacteriology and Parasitology, Tulane National Primate Research Center, Covington, LA, USA.
Lan LuDepartment of Molecular Microbiology, Washington University in St. Louis, St. Louis, MO, USA.
Jose Alberto Choreno-ParraLaboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico.
Stanley Kimbung MbandiSouth African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.ORCID http://orcid.org/0000-0001-6121-9039
Bruce A RosaDivision of Infectious Diseases, Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-6820-446X
Sadia AkterDepartment of Molecular Microbiology, Washington University in St. Louis, St. Louis, MO, USA.
Shibali DasDepartment of Molecular Microbiology, Washington University in St. Louis, St. Louis, MO, USA.
Mushtaq AhmedDepartment of Molecular Microbiology, Washington University in St. Louis, St. Louis, MO, USA.
Maria de la Luz Garcia-HernandezDivision of Allergy, Immunology and Rheumatology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Dhiraj K SinghSouthwest National Primate Research Centre (SNPRC) at Texas Biomedical Research Institute, San Antonio, TX, USA.ORCID http://orcid.org/0000-0001-5507-1197
Ekaterina EsaulovaDepartment of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO, USA.ORCID http://orcid.org/0000-0001-9806-662X
Maxim N ArtyomovDepartment of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-1133-4212
Jennifer GommermanSt. George Campus, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0003-4576-6168
Smriti MehraDivisions of Bacteriology and Parasitology, Tulane National Primate Research Center, Covington, LA, USA.
Joaquin ZunigaLaboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-7143-0281
Makedonka MitrevaDivision of Infectious Diseases, Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA.ORCID http://orcid.org/0000-0001-9572-3436
Thomas J ScribaSouth African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.ORCID http://orcid.org/0000-0002-0641-1359
Javier Rangel-MorenoDivision of Allergy, Immunology and Rheumatology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.ORCID http://orcid.org/0000-0002-9738-1182
Deepak KaushalSouthwest National Primate Research Centre (SNPRC) at Texas Biomedical Research Institute, San Antonio, TX, USA. dkaushal@txbiomed.org.ORCID http://orcid.org/0000-0003-3521-1257
Shabaana A KhaderDepartment of Molecular Microbiology, Washington University in St. Louis, St. Louis, MO, USA. khader@uchicago.edu.ORCID http://orcid.org/0000-0002-9545-4982
Washington University in St. Louis · USInstituto Nacional de Enfermedades Respiratorias · MXJames S. McDonnell Foundation · USTexas Biomedical Research Institute · USTulane University · USUniversity of Cape Town · ZAUniversity of Rochester Medical Center · USUniversity of Toronto · CA

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
Viral Testing CoreU42OD010442 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI SHELLEY A COLE · 2012 to 2026
$35.6M
ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSISR01AI111914 · NIAID · WASHINGTON UNIVERSITY · PI KAUSHAL, DEEPAK, KHADER, SHABAANA A. · 2015 to 2025
$11.1M
Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)P30AR069655 · NIAMS · UNIVERSITY OF ROCHESTER · PI Edward M. Schwarz · 2016 to 2026
$7.8M
ROLE OF IL-17 IN PROTECTIVE VACCINE-INDUCED IMMUNE RESPONSES AGAINST TUBERCULOSISR01HL105427 · NHLBI · WASHINGTON UNIVERSITY · PI KHADER, SHABAANA A. · 2011 to 2025
$5.9M
Immune Correlates of Protection from TBR01AI134240 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI KAUSHAL, DEEPAK · 2017 to 2022
$4.8M
The Role of Group 3 Innate Lymphoid cells (ILC3) in TuberculosisR01AI134236 · NIAID · WASHINGTON UNIVERSITY · PI COLONNA, MARCO, KHADER, SHABAANA A. · 2017 to 2021
$4.4M
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TBR01AI138587 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI JAGANNATH, CHINNASWAMY, KAUSHAL, DEEPAK · 2018 to 2022
$4.4M
COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANSR01AI123780 · NIAID · WASHINGTON UNIVERSITY · PI KAUSHAL, DEEPAK, KHADER, SHABAANA A. · 2016 to 2019
$2.9M
Significant expansion of the SNPRC Specific Pathogen Free Rhesus Macaque Colony for AIDS researchC06OD030079 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI KAUSHAL, DEEPAK · 2021 to 2021
$2.0M
Significant upgrade and expansion of the Southwest National Primate Research Center Pathology UnitS10OD028732 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI KAUSHAL, DEEPAK · 2020 to 2020
$489k
NHLBI NIH HHS R01 HL105427NIAID NIH HHS R01 AI111914NIAID NIH HHS R01 AI123780NIAID NIH HHS R01 AI134236NIAID NIH HHS R01 AI134240NIAID NIH HHS R01 AI138587NIAMS NIH HHS P30 AR069655NIH HHS C06 OD030079NIH HHS P51 OD011104NIH HHS P51 OD011133NIH HHS S10 OD028732NIH HHS U42 OD010442
6 · The paper itself

Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a global cause of death. Granuloma-associated lymphoid tissue (GrALT) correlates with protection during TB, but the mechanisms of protection are not understood. During TB, the transcription factor IRF4 in T cells but not B cells is required for the generation of the T

Indexed as

Mycobacterium tuberculosisTuberculosisAnimalsB-LymphocytesGerminal CenterLymphoid TissueMiceT-Lymphocytes, Helper-InducerTranscription FactorsTranscription Factors

Identifiers

PMID37012543
PMCPMC11133959
OpenAlexW4362522884

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.